Diabetes Devices and Drugs Market, By Category (Diagnosis and Monitoring, Therapeutics ), By Disease Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Diabetes devices and drugs (diagnosis, monitoring and therapeutics) consists of diabetes management right from diagnosis, monitoring, till treatment. Diabetes is characterized by high presence of blood glucose, also called blood sugar, in the body. There are three main types of diabetes: type 1, type 2, and gestational diabetes. Oral glucose tolerance testing and hemoglobin A1c (HbA1c) testing are some of the tests used in the diagnosis of the chronic condition. Treatment options include use of insulin, oral hypoglycemic agents, and others.

Restraints of the Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market

Lack of awareness about diabetes diagnostics and treatment, especially in emerging economies, is expected to hinder growth of the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market. Moreover, recall of diabetes drugs is also expected to limit growth of the market.

Key features of the study:

• This report provides in-depth analysis of the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Abbott Laboratories, Bristol-Myers Squibb, DexCom, Inc., Eli Lilly and Company, Companion Medical, GlaxoSmithKline plc, Glenmark Pharmaceuticals, Johnson & Johnson, Lupin Ltd., F. Hoffmann-La Roche AG, and Sanofi.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

• Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category:
  • Diagnosis and Monitoring
• Blood Glucose Monitoring Devices
• Other Testing Devices
• Software Programs for Diabetes Monitoring
• Artificial Pancreas
  • Therapeutics
• Insulin
• Insulin Delivery
• Oral Hypoglycemic Agents
• Cell Therapies
• Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type:
  • Type 2 Diabetes
  • Type 1 Diabetes
• Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Geography:
  • North America
• By Category
  • Diagnosis and Monitoring
    • Blood Glucose Monitoring Devices
    • Other Testing Devices
    • Software Programs for Diabetes Monitoring
    • Artificial Pancreas
  • Therapeutics
    • Insulin
    • Insulin Delivery
    • Oral Hypoglycemic Agents
    • Cell Therapies
• By Disease Type
  • Type 2 Diabetes
  • Type 1 Diabetes
• By Country:
  • U.S.
  • Canada
  • Europe
• By Category
  • Diagnosis and Monitoring
    • Blood Glucose Monitoring Devices
    • Other Testing Devices
    • Software Programs for Diabetes Monitoring
    • Artificial Pancreas
  • Therapeutics
    • Insulin
    • Insulin Delivery
    • Oral Hypoglycemic Agents
    • Cell Therapies
• By Disease Type
  • Type 2 Diabetes
  • Type 1 Diabetes
• By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• By Category
  • Diagnosis and Monitoring
    • Blood Glucose Monitoring Devices
    • Other Testing Devices
    • Software Programs for Diabetes Monitoring
    • Artificial Pancreas
  • Therapeutics
    • Insulin
    • Insulin Delivery
    • Oral Hypoglycemic Agents
    • Cell Therapies
• By Disease Type
  • Type 2 Diabetes
  • Type 1 Diabetes
• By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• By Category
  • Diagnosis and Monitoring
    • Blood Glucose Monitoring Devices
    • Other Testing Devices
    • Software Programs for Diabetes Monitoring
    • Artificial Pancreas
  • Therapeutics
    • Insulin
    • Insulin Delivery
    • Oral Hypoglycemic Agents
    • Cell Therapies
• By Disease Type
  • Type 2 Diabetes
  • Type 1 Diabetes
• By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
• By Category
  • Diagnosis and Monitoring
    • Blood Glucose Monitoring Devices
    • Other Testing Devices
    • Software Programs for Diabetes Monitoring
    • Artificial Pancreas
  • Therapeutics
    • Insulin
    • Insulin Delivery
    • Oral Hypoglycemic Agents
    • Cell Therapies
• By Disease Type
  • Type 2 Diabetes
  • Type 1 Diabetes
• By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• By Category
  • Diagnosis and Monitoring
    • Blood Glucose Monitoring Devices
    • Other Testing Devices
    • Software Programs for Diabetes Monitoring
    • Artificial Pancreas
  • Therapeutics
    • Insulin
    • Insulin Delivery
    • Oral Hypoglycemic Agents
    • Cell Therapies
• By Disease Type
  • Type 2 Diabetes
  • Type 1 Diabetes
• By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
• Company Profiles
  • Abbott Laboratories *
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
  • Bristol-Myers Squibb
  • DexCom, Inc.
  • Eli Lilly and Company
  • Companion Medical
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals
  • Johnson & Johnson
  • Lupin Ltd.
  • F. Hoffmann-La Roche AG
  • Sanofi

"*" marked represents similar segmentation in other categories in the respective section.